Generate:Biomedicines’ Post

Exciting Insights from Bryan Hill CTO at Cognizant! Discover the game-changing potential of AI in revolutionizing drug development and market launch processes in the life sciences industry. Bryan Hill sheds light on how generative AI can slash years off the typical drug development timeline, translating into faster treatments and revenue opportunities. Key takeaways: Generative AI accelerates research & development by up to 50%, streamlining literature review processes and uncovering new pathways for exploration. Clinical trial protocol writing can be automated, reducing months of work to mere days with the help of AI-generated drafts. Launching therapies in secondary markets becomes more efficient, saving time and resources through automated strategy development and content adaptation. Ready to take the first steps towards AI integration? Bryan emphasizes fostering AI literacy and building partnerships to navigate this transformative journey successfully. Join the life-saving revolution with generative AI! #LifeSciences #AIInnovation #DrugDevelopment https://lnkd.in/eNRHPKZu

The use of AI and ML in drug discovery has the potential to be revolutionary. The Cambridge Structural Database (CSD) is a trusted and high-quality resource that can help drive the AI drug discovery revolution and ensure the quality and trustworthiness of data. Join this upcoming webinar to explore: ✔️The evolving reality of AI/ML in drug discovery. ✔️The value of high-quality, curated data, and why the CSD is trusted globally. ✔️How AI can help the pharma industry.  📅Thursday, 25 July - 4 p.m. (BST) 🔗https://lnkd.in/e3_KSj9e #AI #drugdiscovery #CSD #lifescience

AI is the future and AI will change everything. When this wonderful video by the The Economist was being made, the drug was in Phase IIa clinical trials. And after the video saw the light, the Phase IIa completed with >98mL increase in FVC after just 12 weeks of dosing and we observed dose-dependent response. Please enjoy this episode by the The Economist and kudos to the team and Adam Jessel 📈🧑🔬🤝🤖 #AI #Science https://lnkd.in/grG7i67D

Explore the evolution of drug discovery in Lifebit's blog, which dives deep into its challenges - from target identification to Drug Discovery 2.0, harnessing the power of AI and ML for efficient advancements. Learn more about how we can drive progress within the life sciences sector: https://hubs.li/Q02C3nP70 #DrugDiscovery #AIinHealthcare #Lifebit

I was on vacation while this launched, but excited to share it now. If we hang out, you've definitely heard me talk animatedly about AI-powered virtual cells and the future of biological research. This paper is a vision and roadmap for how they can be used in the future.

In this Forbes article, "High-Demand Human Skills In The Ongoing Age Of AI," Dr. Patrick Smith, President, Drug Development Solutions at Certara and council member of the Forbes Technology Panel, highlights the crucial role of critical thinking and contextualization in leveraging AI effectively. A must-read for anyone interested in the future of AI and human skills! https://ow.ly/qfFH50SrXNS #GenAI #CriticalThinking #RegulatorySubmissions #DrugDevelopment

We are thrilled to have Shiva Amiri leading the charge in AI-driven drug discovery at Pivotal Life Sciences! Acknowledging AI as a crucial tool is transformative, particularly in life sciences, where actionable insights can catalyze significant breakthroughs. While the challenges of data extraction are considerable, the progress we’re making is setting new standards for effective investment strategies in biotech. At Pivotal Life Sciences, we are harnessing the power of AI to foster innovation in healthcare. If you're passionate about the convergence of technology and medicine, don't miss this insightful interview! Check out the full story here. Dive into the full story and discover how AI is shaping the future of healthcare here: https://lnkd.in/e3GybB37

I'm excited to share our new preprint, created in collaboration with leaders in science and AI/ML. It outlines how virtual cell models can transform the field and draws from extensive community discussions and a CZI-hosted workshop where many of the authors contributed. This is our roadmap for the future — developing, implementing, and deploying AI-driven virtual cells will require an #OpenScience approach, broad community involvement, and long-term commitment. https://lnkd.in/gzpJ6zN3

We’re here! Come and meet our Business Development team, Thani Pavlidou, Sunčica Bakić, and Ivana Bogdanović and explore how AI, combined with our Accelerant methodology will bring success to your clinical studies. #clinicalresearch #swissbiotechday #swissbiotechday2024 #Biotechnology

At the Future of Britain Conference 2024, Tony Blair asked Google DeepMind CEO Demis Hassabis about AI's impact on history and innovation. Hassabis likened AI to the Industrial Revolution or the advent of electricity, stressing its transformative potential. He highlighted AI’s role in accelerating scientific discovery and improving public services like the NHS through personalized medicine and drug discovery. Hassabis also discussed the need for further innovations to achieve artificial general intelligence and advocated for the UK to lead in AI cooperation and governance. https://lnkd.in/exG73_72 #AI #Innovation #FutureTech #DeepMind #FutureOfBritain #AIRevolution #TechLeadership